CRL
Charles River Laboratories
$230.88
▼ -0.70%
−$1.63
NYSE · Healthcare · Diagnostics & Research
· price updated 9h ago
Charles River Laboratories
CRL · NYSE · Healthcare · Diagnostics & Research · price updated 9h ago
$230.88
▼ -0.70% · −$1.63 today
AI research · $230.88
Track CRL for continuous AI research
price position
Where CRL sits now
52-week range
Low$144.26
High$237.86
Today $230.88
RSI (14)
52.1Neutral
03070100
fundamentals
Business quality and valuation
Operating record
What the business has actually produced
Revenue
Capital structure
Cash versus debt
Cash & investments$191.8M
Total debt$3.1B
Net cash after debt$-2.9B
Valuation
What the market charges
Forward P/E
Price against expected earnings
Middle ground · In line with Sector avg
19.72x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
2.78x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
28.62x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
33.47x
Quality
How efficiently it compounds
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
9.1%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-5.9%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
1.03x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.36x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
peer comparison
How CRL compares
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $11.20B | - | +0.1% | 46 |
 | $10.69B | 18.4 | +23.5% | 78 |
 | $4.88B | 20.3 | +10.3% | 77 |
 | $31.49B | 32.9 | +15.5% | 77 |
 | $1.08T | 41.4 | +47.4% | 76 |
US stock research
About Charles River Laboratories (CRL) stock
Charles River Laboratories — US core universe (S&P 500 sourced). CRL was -0.7% in the latest available session at $230.88. Its reported market value was $11.20B with a trailing P/E of 0.0. Latest reported revenue was $4.03B, changing +0.1% year over year, with $-184.65M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.
- Latest available price
- $230.88
- Day change
- -0.7%
- Market cap
- $11.20B
- P/E (TTM)
- 0.0
- Revenue growth
- +0.1%
- Industry
- Diagnostics & Research